cystathionine -lyase conducts the , -elimination of cysteine, yielding pyruvate and H 2 S
Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA
No, insomnia is not listed as an adverse reaction in the MHRA Summary of Product Characteristics for Ozempic
reducing reliance on costly imports." Key findings: With 98 GLP-1 drugs in trials, patent expiry in 2026 enabling biosimilars, and a projected $150B market by 2035, China could challenge Western dominancedespite regulatory hurdles and US tariffs
Elevated plasma TMAO levels have been associated in several studies with a higher risk of cardiovascular events and death [11, 67]